|
Fusion gene ID: 23244 |
FusionGeneSummary for MYT1_TCEA2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: MYT1_TCEA2 | Fusion gene ID: 23244 | Hgene | Tgene | Gene symbol | MYT1 | TCEA2 | Gene ID | 9088 | 6919 |
Gene name | protein kinase, membrane associated tyrosine/threonine 1 | transcription elongation factor A2 | |
Synonyms | MYT1|PPP1R126 | TFIIS | |
Cytomap | 16p13.3 | 20q13.33 | |
Type of gene | protein-coding | protein-coding | |
Description | membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinasemyt1 kinaseprotein phosphatase 1, regulatory subunit 126 | transcription elongation factor A protein 2testis-specific S-IItranscription elongation factor A (SII), 2transcription elongation factor S-II protein 2transcription elongation factor TFIIS.1transcription elongation factor TFIIS.l | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | Q01538 | Q15560 | |
Ensembl transtripts involved in fusion gene | ENST00000360149, ENST00000536311, ENST00000328439, | ENST00000361317, ENST00000343484, ENST00000395053, ENST00000465111, | |
Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 1 X 2 X 1=2 |
# samples | 2 | 1 | |
** MAII score | log2(2/8*10)=1.32192809488736 | log2(1/2*10)=2.32192809488736 | |
Context | PubMed: MYT1 [Title/Abstract] AND TCEA2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | MYT1 | GO:0010923 | negative regulation of phosphatase activity | 19389623 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LUSC | TCGA-77-8140-01A | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62697829 | + |
TCGA | LD | LUSC | TCGA-77-8140-01A | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62693783 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-5UTR | ENST00000360149 | ENST00000361317 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62697829 | + |
5UTR-5UTR | ENST00000360149 | ENST00000343484 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62697829 | + |
5UTR-5UTR | ENST00000360149 | ENST00000395053 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62697829 | + |
5UTR-3UTR | ENST00000360149 | ENST00000465111 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62697829 | + |
intron-5UTR | ENST00000536311 | ENST00000361317 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62697829 | + |
intron-5UTR | ENST00000536311 | ENST00000343484 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62697829 | + |
intron-5UTR | ENST00000536311 | ENST00000395053 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62697829 | + |
intron-3UTR | ENST00000536311 | ENST00000465111 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62697829 | + |
intron-5UTR | ENST00000328439 | ENST00000361317 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62697829 | + |
intron-5UTR | ENST00000328439 | ENST00000343484 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62697829 | + |
intron-5UTR | ENST00000328439 | ENST00000395053 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62697829 | + |
intron-3UTR | ENST00000328439 | ENST00000465111 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62697829 | + |
5UTR-5UTR | ENST00000360149 | ENST00000361317 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62693783 | + |
5UTR-intron | ENST00000360149 | ENST00000343484 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62693783 | + |
5UTR-intron | ENST00000360149 | ENST00000395053 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62693783 | + |
5UTR-intron | ENST00000360149 | ENST00000465111 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62693783 | + |
intron-5UTR | ENST00000536311 | ENST00000361317 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62693783 | + |
intron-intron | ENST00000536311 | ENST00000343484 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62693783 | + |
intron-intron | ENST00000536311 | ENST00000395053 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62693783 | + |
intron-intron | ENST00000536311 | ENST00000465111 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62693783 | + |
intron-5UTR | ENST00000328439 | ENST00000361317 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62693783 | + |
intron-intron | ENST00000328439 | ENST00000343484 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62693783 | + |
intron-intron | ENST00000328439 | ENST00000395053 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62693783 | + |
intron-intron | ENST00000328439 | ENST00000465111 | MYT1 | chr20 | 62783263 | + | TCEA2 | chr20 | 62693783 | + |
Top |
FusionProtFeatures for MYT1_TCEA2 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
MYT1 | TCEA2 |
Binds to the promoter region of genes encodingproteolipid proteins of the central nervous system. May play arole in the development of neurons and oligodendroglia in the CNS.May regulate a critical transition point in oligodendrocytelineage development by modulating oligodendrocyte progenitorproliferation relative to terminal differentiation and up-regulation of myelin gene transcription.{ECO:0000269|PubMed:14962745}. | Necessary for efficient RNA polymerase II transcriptionelongation past template-encoded arresting sites. The arrestingsites in DNA have the property of trapping a certain fraction ofelongating RNA polymerases that pass through, resulting in lockedternary complexes. Cleavage of the nascent transcript by S-IIallows the resumption of elongation from the new 3'-terminus.{ECO:0000269|PubMed:12034815}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for MYT1_TCEA2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for MYT1_TCEA2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
MYT1 | PIN1, SIN3B, HDAC1, TRAF3, AURKA | TCEA2 | MAGEA11, TRAF2, AKT1S1, FBF1, CENPT, WDR47, CCSER2, RPA1, SH3GL2, TAX1BP3, DNAJB9, MARK3, CAMKV, MCM2, CAND1, HNRNPK, TNPO1, PNN, EIF4A3, TCEA1, SNW1, NELFA, PARP1, KLC4, MAGED2, POLR2J, APP, LSM4, DHX16, CPSF6, DHRS2, ALAS1, DAB1, GOLGA2, KRTAP5-9, MEOX2, TRIM27, TCF4, TFCP2, MKRN3, TAX1BP1, TNIP1, MID2, EXOSC8, GPKOW, ADAMTSL4, THAP1, TRIM54, CCDC136, TSGA10, CEP44, LZTS2, KRT40, KIAA1958, FAM9B, KRTAP10-7, BRCA1, KXD1, MYH9, ANLN, LMNA |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for MYT1_TCEA2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for MYT1_TCEA2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | TCEA2 | C0023467 | Leukemia, Myelocytic, Acute | 1 | CTD_human |